These medications include semaglutide (Ozempic for diabetes, Wegovy for obesity), liraglutide (Victoza for diabetes, Saxenda for obesity), dulaglutide (Trulicity, approved only for diabetes), and tirzepatide (Mounjaro for diabetes, Zepbound for obesity), which is a dual GLP-1/GIP receptor agonist
-20C, 6 months (sealed storage, away from moisture) Publications (18) Journal Impact Factor Most Recent Nature 2024 Aug;632(8026):903-910
The question of whether a serum "works topically" is largely a function of whether its molecules ever cross the skin barrier
This is why unit dosage in capsule formats is an important factor to consider , as the more quantity in each capsule, the easier it is to reach the recommended daily dose conveniently and efficiently